Stock screenerAll disclosures →
EDGAR →
NTRA
Conviction 80HealthcareScan · Mon, Jul 20, 2026NTRA$262.89-3.13%
ResistanceSupportVol 14Insider sellCongress buyCongress sell9
6
9
4
14
Vol MA14 1.33M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price262.89
Change-3.13%
Gap-1.44%
Rel volume0.79×
Avg volume1.64M
Avg $ vol437.89M
SMA 20268.19
SMA 50233.23
SMA 200216.35
Price vs 50+12.72%
Price vs 200+21.51%
MA stackbullish
50/200 cross—
Supertrendup · 246.37
RSI (14)54
MACD hist-2.93
MACD crossbear · 5d
Stoch %K / %D5 / 28
ADX (14)30
+DI / −DI23 / 16
RSI divergence—
MACD divergence—
ATR %+4.35%
ADR %4.60%
52w high283.80
52w low133.66
From 52w high-7.37%
Above 52w low+96.69%
New 52w highNo
SqueezeOff
Bollinger width20.72%
%B0.40
Donchian pos63.31%
Donchian high288.04
Donchian low219.50
AVWAP (52w high)275.11
vs AVWAP high-4.44%
AVWAP (52w low)207.45
vs AVWAP low+26.72%
OBV trendUp
Chaikin MF (20)0.13
Today vs 20d0.79×
Avg vol (14d)1.33M
Avg vol (20d)1.64M
Avg $ vol (20d)437.89M
Market cap37.65B
RS 3m (vs SPY)+32.45%
RS 6m (vs SPY)+5.80%
RS line new highNo
Trend template8/8
Technical rank81.8
1 week-3.66%
1 month+16.10%
3 months+26.15%
6 months+9.38%
1 year+83.35%
YTD+14.88%
P/E-180.87
P/B21.22
P/S16.33
P/FCF345.05
EPS-1.52
Div yield—
ROE-11.73%
ROA-7.96%
Debt/Eq0.20
Current2.96
EV/EBITDA-140.02
Gross margin1.68%
Net margin-9.03%
Rev growth35.90%
EPS growth-9.31%
Price target281.19
Target upside6.96%
Analyst ratingBuy
Institutional103.88%
Ent. value37.55B
Revenue696.64M
Net income-85.09M
Gross profit723.52M
Free cash flow109.11M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out143.22M
Employees6.14K
ListedThu, Jul 2, 2015
Free float132.15M
Float %95.5%
Short interest5.82M
Days to cover2.8d
Short volume39.8%
Squeeze score23 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.56 vs −$0.53
Last surprise-5.7% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank81.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance285.96
Support200.30
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NTRA · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Josh Gottheimer house · D · NJ · traded 2025-09-22 | Buy | $1K–$15K | 2025-09-22 | 2025-10-15 | |
Josh Gottheimer house · D · NJ · traded 2025-08-22 | Buy | $1K–$15K | 2025-08-22 | 2025-09-05 | |
Josh Gottheimer house · D · NJ · traded 2025-07-22 | Sell | $1K–$15K | 2025-07-22 | 2025-08-11 | |
Josh Gottheimer house · NJ · traded 2024-11-20 | Buy | $1K–$15K | 2024-11-20 | 2024-12-03 |
Insider activity
SEC Form 4 transactions in NTRA · 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Chapman Rowan E Director · Common Stock · 2026-07-15 | Sell | 135 | $37K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 450 | $123K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 90 | $25K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 170 | $47K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 40 | $11K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 390 | $106K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 100 | $27K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 180 | $49K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-15 | Sell | 80 | $22K | 2026-07-15 | 2026-07-17 |
Sheena Jonathan Director · Common Stock · 2026-07-13 | Sell | 500 | $131K | 2026-07-13 | 2026-07-15 |
SEC filings
EDGAR filings in NTRA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.